Emma Lachaier
Publications by Year
Research Areas
COVID-19 Clinical Research Studies, Breast Cancer Treatment Studies, HER2/EGFR in Cancer Research, COVID-19 and healthcare impacts, Advanced Breast Cancer Therapies
Most-Cited Works
- → Switch to fulvestrant and palbociclib versus no switch in advanced breast cancer with rising ESR1 mutation during aromatase inhibitor and palbociclib therapy (PADA-1): a randomised, open-label, multicentre, phase 3 trial(2022)291 cited
- → Risk factors for Coronavirus Disease 2019 (COVID-19) severity and mortality among solid cancer patients and impact of the disease on anticancer treatment: A French nationwide cohort study (GCO-002 CACOVID-19)(2020)164 cited